NeuroPace, Inc. ( NPCE) - Stock Earnings
NPCE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
NPCE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.7 million USD | 26.6 million USD |
| 2026Q1 | -6.7 million USD | 22.1 million USD |
| 2026Q2 | -6.2 million USD | 22.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NPCE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -33.0 million USD | 65.4 million USD |
| 2024 | -27.1 million USD | 79.9 million USD |
| 2025 | -21.5 million USD | 100.0 million USD |
| 2026 Est. | — | — |
NPCE
Price: $12.39
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 24800
Market Capitalization: 433.0 million